Skip to content
HeyJared

The Niche

The Niche (ipscell.com) is a specialized science and policy news outlet focused on stem cell research and adjacent areas of biomedicine.

Outlet · Official site

Indexed articles, last 90 days
9
Latest publication
Aug 2, 2026
Audience
Top 10M sites
Earliest in this view
Jul 5, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 2, 2026 · Professor Paul Knoepfler, Ph.D.

    Weekly reads: FDA warning, Capricor pub vs. AdCom, stem cells can count, hydra regeneration (opens the original)

    Excerpt

    Read excerpt

    How well do FDA warning and untitled letters address what the agency sees as noncompliant activities by unproven stem cell clinics and supplier firms? One might think these letters work well given the implicit threat that not complying with them could lead to more severe action. For instance, the FDA can seek injunctions. Yet, that […] The post Weekly reads: FDA warning, Capricor pub vs. AdCom, stem cells can count, hydra regeneration appeared first on <a hr

  2. Article · Jul 31, 2026 · Parmin Sedigh

    A Look Back on ISSCR 2026: the most exciting research (opens the original)

    Excerpt

    Read excerpt

    They say you never forget your first international conference. They’re right. Last week, I attended ISSCR 2026 as an undergraduate student. I was admittedly nervous at the start, but by the time the end of the second day rolled around, and with it the all-attendee reception, all the ice had melted and the excitement was […] The post A Look Back on ISSCR 2026: the most exciting research appeared first on The Niche.</p

  3. Article · Jul 29, 2026 · Professor Paul Knoepfler, Ph.D.

    More farce or tragedy? What’s ahead after RFK Jr.’s PCAC kangaroo meeting green lit risky peptides (opens the original)

    Excerpt

    Read excerpt

    As I was watching the PCAC meetings late last week on popular so-called wellness or pop peptides, a neologism jumped to mind: kangaroo meeting. I almost felt like this PCAC meeting was a theatrical play. I can’t decide if it was more tragedy or farce. We watched as some conflicted panel members participated and voted […] The post More farce or tragedy? What’s ahead after RFK Jr.’s PCAC kangaroo meeting green lit risky peptides appe

  4. Article · Jul 26, 2026 · Professor Paul Knoepfler, Ph.D.

    Weekly reads: MYC phosphorylation, reverse protein aging, mitochondria don’t like space, that peptide committee (opens the original)

    Excerpt

    Read excerpt

    Why am I interested in MYC phosphorylation? What is MYC? Long-time readers of The Niche probably remember that the MYC family is one of my primary interests. These proteins are essential for normal development (and stem cell function) as well as contributing to the formation of many tumors when overexpressed or mutated. MYC was also […] The post Weekly reads: MYC phosphorylation, reverse protein aging, mitochondria don’t like space, th

  5. Article · Jul 21, 2026 · Professor Paul Knoepfler, Ph.D.

    Potentially highly-conflicted PCAC meets this week on pop peptides, but no waivers (opens the original)

    Excerpt

    Read excerpt

    So-called wellness peptides are even more in the spotlight this week as the pharmacy compounding advisory committee or PCAC launches a series of meetings to evaluate restoration of compounding of these unproven peptide drugs. This committee is supposed to take FDA staff guidance into consideration as it decides what to recommend to the agency. Typically […] The post Potentially highly-conflicted PCAC meets this week on pop peptides, but no waivers appeared first

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 10M sites

Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

How this was measured

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about The Niche